ヨーロッパの迅速診断検査 (RDT) 市場 – 業界動向と 2031 年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Healthcare ヨーロッパの迅速診断検査 (RDT) 市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパの迅速診断検査 (RDT) 市場 – 業界動向と 2031 年までの予測

  • Healthcare
  • Published Report
  • Feb 2024
  • Europe
  • 350 ページ
  • テーブル数: 244
  • 図の数: 59
Buy Now 今すぐ購入

ヨーロッパの迅速診断検査 (RDT) 市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
 2024 –2031
Diagram 市場規模（基準年）
 USD 12.05 Billion
Diagram Market Size (Forecast Year)
 USD 21.64 Billion
Diagram CAGR
 %
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>ヨーロッパの迅速診断検査 (RDT) 市場、製品タイプ別 (消耗品およびキット、器具、その他)、モード別 (専門家向けおよび店頭販売 [OTC])、技術別 (PCR ベース、フロースルー アッセイ、ラテラル フロー免疫クロマトグラフィー アッセイ、凝集アッセイ、マイクロ流体、基質技術、その他)、モダリティ別 (ラボベースのテストおよび非ラボベースのテスト)、年齢層別 (成人および小児)、テスト タイプ別 (確定診断、血清学的テストおよびウイルス配列決定)、アプローチ別 (体外診断および分子診断)、検体別 (綿棒、血液、尿、唾液、痰、その他)、アプリケーション別 (感染症検査、グルコース モニタリング、心臓病検査、腫瘍学検査、心臓代謝検査、薬物乱用検査、妊娠および生殖能力検査、毒物学)医療機器（検査、その他）、エンドユーザー（病院・診療所、診断研究所、在宅ケア環境、研究・学術機関、その他）、流通チャネル（直接入札および小売販売） - 2031 年までの業界動向と予測。

欧州の迅速診断検査（RDT）市場

ヨーロッパの迅速診断検査 (RDT) 市場分析と洞察  

ヒト免疫不全ウイルス（HIV）、マラリア、その他の病気などの慢性感染症の診断のための迅速診断テストの増加が市場の成長を牽引しています。熟練した専門家の不足により、診断中に多くの事故やエラーが発生しており、市場の成長に課題が残ると予想されます。

欧州の迅速診断検査（RDT）市場欧州の迅速診断検査（RDT）市場

データブリッジマーケットリサーチは、ヨーロッパの迅速診断検査（RDT）市場は、2023年の120億5,000万米ドルから2031年には216億4,000万米ドルに達し、2024年から2031年の予測期間に8.2％の健全なCAGRで成長すると分析しています。

レポートメトリック

詳細

予測期間

2024年から2031年

基準年

2023

歴史的な年

2022 (2016～2021年にカスタマイズ可能)

定量単位

収益（10億米ドル）

対象セグメント

製品タイプ（消耗品およびキット、器具、その他）、モード（専門家向けおよび市販薬（OTC））、技術（PCR ベース、フロースルーアッセイ、ラテラルフロー免疫クロマトグラフィーアッセイ、凝集アッセイ、マイクロ流体、基質技術、その他）、モダリティ（ラボベースのテストおよび非ラボベースのテスト）、年齢層（成人および小児）、テストの種類（確定診断、血清学的テストおよびウイルス配列）、アプローチ（体外診断および分子診断）、検体（綿棒、血液、尿、唾液、痰、その他）、アプリケーション（感染症検査、グルコースモニタリング、心臓病学検査、腫瘍学検査、心臓代謝検査、薬物乱用検査、妊娠および生殖能力検査、毒物学検査、その他）、エンドユーザー（病院および医療機関）診療所、診断研究所、在宅ケア施設、研究・学術機関、その他）、流通チャネル（直接入札および小売販売）

対象国

ドイツ、フランス、イギリス、イタリア、スペイン、ロシア、トルコ、ベルギー、オランダ、スイス、その他のヨーロッパ諸国

対象となる市場プレーヤー

Abbott、Danaher、Cellex、Fujirebio、AdvaCare Pharma、ACCESS BIO、Cardinal Health、Bio-Rad Laboratories、Inc.、Cepheid、BD、F. Hoffmann-La Roche Ltd、bioMérieux SA、InBios International、Inc.、Luminex Corporation、Gnomegen LLC、QIAGEN、Quidel Corporation、、Inc.、Sysmex Corporation、Cardinal Health、Siemens Healthcare Gmbh、MEGACOR DIAGNOSTIK、PerkinElmer Inc.、Sekisui Diagnostics、PTS Diagnostics、werfen、Nova Biomedical、Trinity Biotech など

市場の定義

迅速診断検査は、いくつかの状況 (敗血症、呼吸器感染症、髄膜炎など) で感染症の病因分析を促進できるため、標準診断検査よりも好まれます。現在利用可能な迅速診断検査の解明は必ずしも前向きではないため、従来の検査に取って代わることはまだできません。迅速診断検査には 3 つのタイプがあります。迅速免疫測定検査ストリップまたはカセットは、化学物質の濃度を測定するために使用されます。検査ストリップは、サンプル内の液体の pH レベルを検査するために最もよく使用されますが、一部のタイプの検査ストリップは、汚染物質の存在を検出するなど、他の目的にも使用されます。

ヨーロッパの迅速診断検査 (RDT) 市場の動向

ドライバー

  • 慢性疾患の発症率の増加

市場の成長を牽引する要因は、慢性疾患の発生率の増加、高齢者人口の増加、迅速診断テストの技術開発、および製品発売の増加です。ただし、市場を抑制する要因として予想されるのは、迅速診断のコスト上昇、迅速診断テストで直面する製品リコール、および迅速診断の使用に関する認識の欠如です。さらに、市場プレーヤーによる戦略的イニシアチブと医療費の増加が市場の成長を後押ししています。

  • 感染症の高齢者人口の増加

世界中の高齢化社会は、免疫システムの変化、ライフスタイル、環境要因への長期にわたる曝露など、さまざまな要因により、慢性疾患や悪性疾患のリスクが高まっています。高齢者がこのような健康問題にかかりやすいことから、これらの状態を特定して管理するための効果的かつ効率的な診断ツールの重要性が浮き彫りになっています。この点で注目すべき点の 1 つは、高齢者に非特異的抗体が多く存在し、特定の疾患の検出がより困難になっていることです。

欧州の迅速診断検査（RDT）市場

機会

  • 市場プレーヤーによる戦略的開始と製品発売

市場では、新製品や新発売の増加という注目すべき傾向が見られます。このイノベーションの急増は、診断環境のダイナミックな性質を強調しており、企業は進化する医療ニーズに対応するために新しいソリューションを積極的に導入しています。特に人口の高齢化を背景に、正確で迅速な診断ツールに対する需要が高まっており、研究開発への投資が増加しています。

制約/課題

  • 迅速診断キットの高コスト

迅速診断キットのコストは、研究と有効性が強化されたことにより上昇しています。しかし、使用される材料の価格と、治療薬やサービスの開発により、病原体の生存能力を診断およびスクリーニングするために必要な製造ユニットの数と労働力と人的資源が増加します。

迅速な診断の開発コストは高額であり、適切なプロトコル調達戦略が必要です。しかし、専門クリニックや診断研究所は、財政状況の悪さから検査機器の購入に支障をきたしており、検査キットやその付属品の販売が制限される可能性があります。

  • 市場承認のための厳格な規制

規制は、体外診断や分子診断などの迅速診断テストのあらゆる側面を対象としています。これらの規則と規制は、患者のセキュリティと安全性を確保するために市場承認に必要です。

法的形式上のこれらの規制承認を取得するには、多額の費用がかかる可能性があり、完了するまでに数か月または数年かかる可能性があります。これらの制限が認識されていないか考慮されていない場合、競争の激しい市場で成功する可能性は遅延によって大幅に低下し、市場の成長に支障をきたす可能性があります。

最近の動向

  •  2023年5月、F.ホフマン・ラ・ロッシュ株式会社はストラトス・ゲノミクスの買収を正式に発表しました。この買収により、診断用のDNAベースのシーケンシングが開発されました。これにより、同社のヘルスケア診断部門が強化され、収益の増加につながりました。
  • 2023年4月、7月には、呼吸器感染症の原因となるSARS-CoV-2感染を含む23の病原体を検査するbioMérieux SAのBIOFIRE呼吸器パネル2.1プラスが世界中で販売され、呼吸器感染症の早期診断に役立ちます。この開発により、同社はより多くの収益を生み出すことができました。

欧州の迅速診断検査（RDT）市場の範囲

ヨーロッパの迅速診断テスト (RDT) 市場は、製品タイプ、モード、テクノロジー、モダリティ、年齢層、テストの種類、アプローチ、検体、アプリケーション、エンドユーザー、流通チャネルに基づいて、11 の重要なセグメントに分類されています。これらのセグメントの成長は、業界の主要な成長セグメントの分析に役立ち、ユーザーに貴重な市場の概要と市場の洞察を提供し、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。

 製品タイプ

  • 楽器
  • 消耗品とキット
  • その他

製品タイプに基づいて、市場は消耗品とキット、機器、その他に分類されます。

モード

  • 市販薬[OTC]
  • プロ

モードに基づいて、市場はプロフェッショナル向けと店頭販売（OTC）向けに分割されます。

 テクノロジー

  • PCRベース
  • フロースルーアッセイ
  • ラテラルフロー免疫クロマトグラフィーアッセイ
  • マイクロ流体
  • 基板技術
  • 凝集アッセイ
  • その他

技術に基づいて、市場はPCRベース、フロースルーアッセイ、ラテラルフロー免疫クロマトグラフィーアッセイ、凝集アッセイ、マイクロ流体、基質技術などに分類されます。

モダリティ

  • 実験室ベースのテスト
  • 非実験室ベースのテスト

モダリティに基づいて、市場は実験室ベースのテストと非実験室ベースのテストに分類されます。

年齢層

  • 小児科
  • アダルト

年齢層に基づいて、市場は成人用と小児用に分割されます。

テストの種類

  • 確認の決定
  • 血清学的検査
  • ウイルス配列解析

検査の種類に基づいて、市場は確定検査、血清学的検査、およびウイルス配列決定に分類されます。

アプローチ

  • 分子診断
  • 体外診断

アプローチに基づいて、市場は体外診断と分子診断に分類されます。

検体

  • 綿棒
  • 血
  • 尿
  • 唾液
  • 喀痰
  • その他

 検体に基づいて、市場は綿棒、血液、尿、唾液、痰、その他に分類されます。

応用

  • 感染症検査
  • 心臓病検査
  • 腫瘍学検査
  • 妊娠と不妊検査
  • 毒性試験
  • 乱用薬物検査
  • 心臓代謝検査
  • 血糖モニタリング
  • その他

アプリケーションに基づいて、市場は感染症検査、血糖モニタリング、心臓病検査、腫瘍学検査、心臓代謝検査、乱用薬物検査、妊娠および生殖能力検査、毒物学検査、その他に分類されます。

エンドユーザー

  • 病院・クリニック
  • 診断検査室
  • 在宅ケア環境
  • 研究・学術機関
  • その他

エンドユーザーに基づいて、市場は病院と診療所、診断研究所、在宅ケア環境、研究および学術機関、その他に分類されます。

流通チャネル

  • 直接入札
  • 小売販売

流通チャネルに基づいて、市場は直接入札と小売販売に分割されます。

欧州の迅速診断検査（RDT）市場

地域分析: ヨーロッパの迅速診断検査 (RDT) 市場

ヨーロッパの迅速診断テスト (RDT) 市場が分析され、製品タイプ、モード、テクノロジー、モダリティ、年齢層、テストの種類、アプローチ、検体、アプリケーション、エンドユーザー、流通チャネルに関する市場規模の情報が提供されます。

ヨーロッパ迅速診断検査 (RDT) 市場レポートで取り上げられている国は、ドイツ、フランス、イギリス、イタリア、スペイン、ロシア、トルコ、ベルギー、オランダ、スイス、およびその他のヨーロッパ諸国です。 

ドイツは、主要な市場プレーヤーの存在と、この地域におけるヨーロッパの迅速診断検査の技術的進歩の増加により、市場で優位に立つと予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。  

欧州の迅速診断検査 (RDT) 市場: 競争環境とシェア分析

ヨーロッパの迅速診断テスト (RDT) 市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、ヨーロッパの迅速診断テスト市場に関連する会社の焦点にのみ関連しています。

ヨーロッパの迅速診断テスト (RDT) 市場を提供している主要企業には、Abbott、Danaher、Cellex、Fujirebio、Pharma、Access Bio、Cardinal Health、Bio-Rad Laboratories、Inc.、BD、F. Hoffmann-La Roche Ltd、BIOMÉRIEUX SA、InBios International、Inc、Luminex Corporation、A DiaSorin Company、Gnomegen LLC、QIAGEN、Quidel Corporation、Sysmex Europe Gmbh (Sysmex Corporation の子会社)、Cardinal Health、Siemens Healthcare Gmbh (Siemens Healthineers AG の子会社)、MEGACOR DIAGNOSTIK GMBH、PerkinElmer Inc.、Sekisui Diagnostics、PTS Diagnostics、werfen、Nova Biomedical、Trinity Biotech などがあります。    

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE RAPID DIAGNOSTIC TESTS (RTD) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET APPLICATION COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASE IN INCIDENCE OF CHRONIC DISEASES

5.1.2 RISE IN GERIATRIC POPULATION OF THE INFECTIOUS DISEASES

5.1.3 TECHNOLOGICAL ADVANCEMENTS IN RAPID DIAGNOSTIC TESTING

5.1.4 GOVERNMENT INITIATIVES FOR DIAGNOSIS OF INFECTIOUS DISEASES

5.2 RESTRAINTS

5.2.1 HIGH COST ASSOCIATED WITH THE RAPID DIAGNOSTIC KITS

5.2.2 PRODUCT RECALLS IN RAPID DIAGNOSTIC TESTS

5.2.3 LACK OF AWARENESS ABOUT RAPID DIAGNOSTIC TESTING OF THE DISEASES

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATION AND PRODUCT LAUNCHES BY MARKET PLAYERS

5.3.2 RISE IN GOVERNMENT SUPPORT AND FUNDING FOR RAPID DIAGNOSTIC TEST

5.3.3 INCREASING AWARENESS ABOUT THE PROMPT AND EFFICIENT DIAGNOSIS

4.1 CHALLENGES

5.3.4 STRINGENT REGULATORY FOR MARKET APPROVAL

5.3.5 LACK OF TRAINING AND EXPERTISE IN THE DIAGNOSTIC CENTRES

6 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 CONSUMABLES AND KITS

6.2.1 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

6.2.2 IMMUNOCHROMATOGRAPHIC ASSAY

6.2.2.1 ANTIBODY TESTS

6.2.2.1.1 TOTAL ANTIBODY ELISA KIT

6.2.2.1.2 IGM/IGG RAPID DIAGNOSTIC TEST

6.2.2.1.3 IGG ELISA KIT

6.2.2.1.4 IGM ELISA KIT

6.2.2.1.5 NEUTRALIZING ANTIBODY ELISA KIT

6.2.3 ANTIGEN ELISA KITS

6.2.4 SPECIMEN COLLECTION KIT

6.3 RT-PCR ASSAY KITS

6.3.1 REVERSE TRANSCRIPTION PCR (RT-PCR)

6.3.2 QUANTITATIVE REVERSE TRANSCRIPTION PCR (RT-QPCR)

6.3.3 OTHERS

6.4 INSTRUMENTS

6.4.1 PORTABLE

6.4.2 BENCHTOP

6.4.3 FIXED

6.5 OTHERS

7 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE

7.1 OVERVIEW

7.2 PROFESSIONAL

7.3 OVER-THE-COUNTER [OTC]

8 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 PCR-BASED

8.3 FLOW-THROUGH ASSAYS

8.4 LATERAL FLOW IMMUNOCHROMATOGRAPHIC ASSAYS

8.5 AGGLUTINATION ASSAY

 

8.6 MICROFLUIDICS

8.6.1 PAPER-BASED MICROFLUDICS

8.6.2 LUCIFERASE IMMUNOPRECIPITATION SYSTEMS (LIPS)

8.6.3 OTHERS

8.7 SUBSTRATE TECHNOLOGY

8.8 OTHERS

9 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY

9.1 OVERVIEW

9.2 LABORATORY BASED TEST

9.3 NON-LABORATORY BASED TEST

10 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP

10.1 OVERVIEW

10.2 ADULT

10.3 PEDIATRIC

11 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE

11.1 OVERVIEW

11.2 DETERMINING CONFIRMATION

11.2.1 RT-PCR ASSAY KITS

11.2.2 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

11.2.3 IMMUNOCHROMATOGRAPHIC ASSAY

11.2.4 OTHERS

11.3 SEROLOGICAL TESTING

11.3.1 RT-PCR ASSAY KITS

11.3.2 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

11.3.3 IMMUNOCHROMATOGRAPHIC ASSAY

11.3.4 OTHERS

11.4 VIRAL SEQUENCING

11.4.1 RT-PCR ASSAY KITS

11.4.2 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

11.4.3 IMMUNOCHROMATOGRAPHIC ASSAY

11.4.4 OTHERS

12 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH

12.1 OVERVIEW

12.2 IN-VITRO DIAGNOSTIC

12.3 MOLECULAR DIAGNOSTIC

 

13 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN

13.1 OVERVIEW

13.2 SWAB

13.3 BLOOD

13.4 URINE

13.5 SALIVA

13.6 SPUTUM

13.7 OTHERS

14 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 INFECTIOUS DISEASE TESTING

14.2.1 VIRUS

14.2.2 BACTERIA

14.2.3 OTHERS

14.3 GLUCOSE MONITORING

14.4 CARDIOLOGY TESTING

14.5 ONCOLOGY TESTING

14.5.1 LUNG CANCER

14.5.2 BREAST CANCER

14.5.3 BLOOD CANCER

14.5.4 OTHERS

14.6 CARDIOMETABOLIC TESTING

14.7 DRUGS-OF-ABUSE TESTING

14.8 PREGNANCY & FERTILITY TESTING

14.9 TOXICOLOGY TESTING

14.1 OTHERS

15 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITAL & CLINIC

15.3 DIAGNOSTIC LABORATORY

15.4 HOME CARE SETTING

15.5 RESEARCH AND ACADEMIC INSTITUTES

15.6 OTHERS

16 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 RETAIL SALES

17 EUROPE BY COUNTRY

17.1 OVERVIEW

17.1.1 GERMANY

17.1.2 FRANCE

17.1.3 U.K.

17.1.4 ITALY

17.1.5 SPAIN

17.1.6 RUSSIA

17.1.7 TURKEY

17.1.8 BELGIUM

17.1.9 NETHERLANDS

17.1.10 SWITZERLAND

17.1.11 REST OF EUROPE

18 EUROPE RAPID DIAGNOSTICS TESTS (RDT) MARKET: COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: EUROPE

19 SWOT ANALYSIS

20 COMPANY PROFILES

20.1 ABBOTT

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENTS

20.2 F. HOFFMANN-LA ROCHE LTD

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 PRODUCT PORTFOLIO

20.2.4 RECENT DEVELOPMENTS

20.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENTS

20.4 PTS DIAGNOSTICS

20.4.1 COMPANY SNAPSHOT

20.4.2 PRODUCT PORTFOLIO

20.4.3 RECENT DEVELOPMENTS

 

20.5 CARDINAL HEALTH

20.5.1 COMPANY SNAPSHOT

20.5.2 REVENUE ANALYSIS

20.5.3 PRODUCT PORTFOLIO

20.5.4 RECENT DEVELOPMENT

20.6 ACCESS BIO

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENTS

20.7 BD

20.7.1 COMPANY SNAPSHOT

20.7.2 REVENUE ANALYSIS

20.7.3 PRODUCT PORTFOLIO

20.7.4 RECENT DEVELOPMENTS

20.8 BIOMÉRIEUX SA

20.8.1 COMPANY SNAPSHOT

20.8.2 REVENUE ANALYSIS

20.8.3 PRODUCT PORTFOLIO

20.8.4 RECENT DEVELOPMENT

20.9 BIO-RAD LABORATORIES, INC.

20.9.1 COMPANY SNAPSHOT

20.9.2 REVENUE ANALYSIS

20.9.3 PRODUCT PORTFOLIO

20.9.4 RECENT DEVELOPMENTS

20.1 CELLEX

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENTS

20.11 DANAHER

20.11.1 COMPANY SNAPSHOT

20.11.2 REVENUE ANALYSIS

20.11.3 PRODUCT PORTFOLIO

20.11.4 RECENT DEVELOPMENTS

20.12 FUJIREBIO (A SUBSIDIARY OF H.U. GROUP)

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENTS

 

20.13 GNOMEGAN LLC

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENT

20.14 INBIOS INTERNATIONAL, INC

20.14.1 COMPANY SNAPSHOT

20.14.2 PRODUCT PORTFOLIO

20.14.3 RECENT DEVELOPMENTS

20.15 LUMINEX CORPORATION, A DIASORIN COMPANY

20.15.1 COMPANY SNAPSHOT

20.15.2 PRODUCT PORTFOLIO

20.15.3 RECENT DEVELOPMENT

20.16 MEGAKOR DIAGNOSTIK GMBH

20.16.1 COMPANY SNAPSHOT

20.16.2 PRODUCT PORTFOLIO

20.16.3 RECENT DEVELOPMENT

20.17 NOVA BIOMEDICAL

20.17.1 COMPANY SNAPSHOT

20.17.2 PRODUCT PORTFOLIO

20.17.3 RECENT DEVELOPMENTS

20.18 PERKIN ELMER INC.

20.18.1 COMPANY SNAPSHOT

20.18.2 REVENUE ANALYSIS

20.18.3 PRODUCT PORTFOLIO

20.18.4 RECENT DEVELOPMENTS

20.19 QIAGEN

20.19.1 COMPANY SNAPSHOT

20.19.2 REVENUE ANALYSIS

20.19.3 PRODUCT PORTFOLIO

20.19.4 RECENT DEVELOPMENT

20.2 QUIDEL CORPORATION

20.20.1 COMPANY SNAPSHOT

20.20.2 REVENUE ANALYSIS

20.20.3 PRODUCT PORTFOLIO

20.20.4 RECENT DEVELOPMENTS

20.21 SEKISUI DIAGNOSTICS

20.21.1 COMPANY SNAPSHOT

20.21.2 PRODUCT PORTFOLIO

20.21.3 RECENT DEVELOPMENTS

 

20.22 SYSMEX EUROPE GMBH (A SUBSIDIARY OF SYSMEX CORPORATION)

20.22.1 COMPANY SNAPSHOT

20.22.2 REVENUE ANALYSIS

20.22.3 PRODUCT PORTFOLIO

20.22.4 RECENT DEVELOPMENTS

20.23 TRINITY BIOTECH

20.23.1 COMPANY SNAPSHOT

20.23.2 REVENUE ANALYSIS

20.23.3 PRODUCT PORTFOLIO

20.23.4 RECENT DEVELOPMENT

20.24 WERFEN

20.24.1 COMPANY SNAPSHOT

20.24.2 PRODUCT PORTFOLIO

20.24.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

表のリスト

TABLE 1 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 2 EUROPE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 3 EUROPE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 4 EUROPE ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 5 EUROPE RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 6 EUROPE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 7 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 8 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 9 EUROPE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 10 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 11 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 12 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 13 EUROPE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 14 EUROPE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 15 EUROPE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 16 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 17 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 18 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 19 EUROPE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 20 EUROPE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 21 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 22 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 23 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 24 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 25 GERMANY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 26 GERMANY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 27 GERMANY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 28 GERMANY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 29 GERMANY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 30 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 31 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 32 GERMANY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 33 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 34 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 35 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 36 GERMANY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 37 GERMANY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 38 GERMANY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 39 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 40 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 41 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 42 GERMANY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 43 GERMANY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 44 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 45 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 47 FRANCE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 48 FRANCE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 49 FRANCE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 50 FRANCE RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 51 FRANCE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 52 FRANCE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 53 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 54 FRANCE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 55 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 56 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 57 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 58 FRANCE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 59 FRANCE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 60 FRANCE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 61 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 62 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 63 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 64 FRANCE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 65 FRANCE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 66 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 67 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 68 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 69 U.K. CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 70 U.K. IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 71 U.K. ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 72 U.K. RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 73 U.K. INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 74 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 75 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 76 U.K. MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 77 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 78 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 79 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 80 U.K. DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 81 U.K. SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 82 U.K. VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 83 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 84 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 85 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 86 U.K. INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 87 U.K. ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 88 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 89 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 90 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 91 ITALY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 92 ITALY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 93 ITALY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 94 ITALY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 95 ITALY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 96 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 97 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 98 ITALY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 99 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 100 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 101 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 102 ITALY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 103 ITALY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 104 ITALY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 105 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 106 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 107 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 108 ITALY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 109 ITALY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 110 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 111 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 112 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 113 SPAIN CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 114 SPAIN IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 115 SPAIN ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 116 SPAIN RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 117 SPAIN INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 118 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 119 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 120 SPAIN MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 121 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 122 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 123 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 124 SPAIN DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 125 SPAIN SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 126 SPAIN VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 127 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 128 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 129 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 130 SPAIN INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 131 SPAIN ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 132 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 133 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 134 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 135 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 136 RUSSIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 137 RUSSIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 138 RUSSIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 139 RUSSIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 140 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 141 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 142 RUSSIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 143 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 144 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 145 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 146 RUSSIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 147 RUSSIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 148 RUSSIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 149 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 150 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 151 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 152 RUSSIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 153 RUSSIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 154 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 155 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 156 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 157 TURKEY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 158 TURKEY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 159 TURKEY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 160 TURKEY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 161 TURKEY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 162 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 163 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 164 TURKEY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 165 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 166 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 167 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 168 TURKEY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 169 TURKEY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 170 TURKEY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 171 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 172 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 173 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 174 TURKEY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 175 TURKEY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 176 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 177 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 178 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 179 BELGIUM CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 180 BELGIUM IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 181 BELGIUM ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 182 BELGIUM RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 183 BELGIUM INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 184 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 185 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 186 BELGIUM MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 187 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 188 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 189 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 190 BELGIUM DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 191 BELGIUM SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 192 BELGIUM VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 193 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROCH, 2022-2031 (USD MILLION)

TABLE 194 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 195 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 196 BELGIUM INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 197 BELGIUM ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 198 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 199 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 200 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 201 NETHERLANDS CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 202 NETHERLANDS IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 203 NETHERLANDS ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 204 NETHERLANDS RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 205 NETHERLANDS INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 206 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 207 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 208 NETHERLANDS MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 209 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 210 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 211 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 212 NETHERLANDS DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 213 NETHERLANDS SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 214 NETHERLANDS VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 215 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROCH, 2022-2031 (USD MILLION)

TABLE 216 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 217 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 218 NETHERLANDS INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 219 NETHERLANDS ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 220 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 221 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 222 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 223 SWITZERLAND CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 224 SWITZERLAND IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 225 SWITZERLAND ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 226 SWITZERLAND RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 227 SWITZERLAND INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 228 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 229 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 230 SWITZERLAND MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 231 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 232 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 233 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 234 SWITZERLAND DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 235 SWITZERLAND SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 236 SWITZERLAND VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 237 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 238 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 239 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 240 SWITZERLAND INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 241 SWITZERLAND ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 242 SWITZERLAND ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 243 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 244 REST OF EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

図表一覧

FIGURE 1 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SEGMENTATION

FIGURE 2 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: DROC ANALYSIS

FIGURE 4 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE RAPID DIAGNOSTIC TESTS (RTD) MARKET: DBMR POSITION GRID

FIGURE 8 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: APPLICATION COVERAGE GRID

FIGURE 10 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SEGMENTATION

FIGURE 11 THE INCREASED BURDEN OF INFECTIOUS DISEASES, RISE IN AWARENESS OF RAPID DIAGNOSTIC TESTS, AND RISE IN PRODUCT LAUNCHES ARE DRIVING THE GROWTH OF THE EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET FROM 2024 TO 2031

FIGURE 12 CONSUMABLES AND KITS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET FROM 2024 TO 2031

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE RAPID DIAGNOSTIC TESTS (RTD) MARKET

FIGURE 14 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, 2023

FIGURE 15 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 16 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 17 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, 2023

FIGURE 19 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, 2024-2031 (USD MILLION)

FIGURE 20 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, CAGR (2024-2031)

FIGURE 21 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, LIFELINE CURVE

FIGURE 22 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, 2023

FIGURE 23 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, 2024-2031 (USD MILLION)

FIGURE 24 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, CAGR (2024-2031)

FIGURE 25 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 26 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, 2023

FIGURE 27 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, 2024-2031 (USD MILLION)

FIGURE 28 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, CAGR (2024-2031)

FIGURE 29 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 30 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, 2023

FIGURE 31 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, 2024-2031 (USD MILLION)

FIGURE 32 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, CAGR (2024-2031)

FIGURE 33 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 34 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, 2023

FIGURE 35 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, 2024-2031 (USD MILLION)

FIGURE 36 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, CAGR (2024-2031)

FIGURE 37 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 38 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, 2023

FIGURE 39 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, 2024-2031 (USD MILLION)

FIGURE 40 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, CAGR (2024-2031)

FIGURE 41 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, LIFELINE CURVE

FIGURE 42 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, 2023

FIGURE 43 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, 2024-2031 (USD MILLION)

FIGURE 44 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, CAGR (2024-2031)

FIGURE 45 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, LIFELINE CURVE

FIGURE 46 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, 2023

FIGURE 47 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 48 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 49 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 50 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, 2023

FIGURE 51 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 52 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, CAGR (2024-2031)

FIGURE 53 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 54 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 55 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 56 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 57 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 58 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SNAPSHOT (2023)

FIGURE 59 EUROPE RAPID DIAGNOSTICS TESTS (RDT) MARKET: COMPANY SHARE 2023 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The rapid diagnostic tests (RDT) industry was worth USD 12.05 billion in 2023 & it is projected to reach USD 21.64 billion by 2031.
The growth rate of the Europe rapid diagnostic tests (RDT) market is 8.2%.
Increase in the incidence of chronic diseases & rise in geriatric population of the infectious diseases are the growth drivers of the Europe rapid diagnostic tests (RDT) market.
Product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel are the factors on which the Europe rapid diagnostic tests (RDT) market research is based.
Major companies in the Europe rapid diagnostic tests (RDT) market are Abbott, Danaher, Cellex, Fujirebio, AdvaCare Pharma, ACCESS BIO, Cardinal Health, Bio-Rad Laboratories, Inc., Cepheid, BD, F. Hoffmann-La Roche Ltd, bioMérieux SA, InBios International, Inc, Luminex Corporation, Gnomegen LLC, QIAGEN, Quidel Corporation, , Inc., Sysmex Corporation, Cardinal Health, Siemens Healthcare Gmbh, MEGACOR DIAGNOSTIK, PerkinElmer Inc., Sekisui Diagnostics, PTS Diagnostics, werfen, Nova Biomedical, and Trinity Biotech among others.

関連ページを閲覧する

Banner